Eupraxia Pharmaceuticals Inc.
EPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001581178
No open-market purchases or sales by Eupraxia Pharmaceuticals Inc. insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $163.6M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Eupraxia Pharmaceuticals Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 27 | 36 | +9 |
| Shares | 12.8M | 13.9M | +1.14M (+8.9%) |
| Value | $75.3M | $105.1M | +$29.8M (+39.6%) |
New holders (15)
Institutions that held Eupraxia Pharmaceuticals Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 712,104 | $5.38M | 0.01% |
| Ikarian Capital, LLC | 610,000 | $4.61M | 0.60% |
| Squadron Capital Management LLC | 500,000 | $3.77M | 1.68% |
| Arrowstreet Capital, Limited Partnership | 278,064 | $2.09M | 0.00% |
| SummitTX Capital, L.P. | 175,948 | $1.33M | 0.04% |
| Marshall Wace, LLP | 158,133 | $1.19M | 0.00% |
| Boothbay Fund Management, LLC | 156,331 | $1.18M | 0.03% |
| Delaney Capital Management Ltd. | 119,400 | $899.0K | 0.15% |
| Quadrature Capital Ltd | 43,186 | $325.6K | 0.00% |
| 1832 Asset Management L.P. | 32,138 | $242.6K | 0.00% |
| Jane Street Group, LLC | 29,622 | $222.8K | 0.00% |
| XTX Topco Ltd | 16,180 | $122.2K | 0.00% |
| Geode Capital Management, LLC | 13,899 | $104.9K | 0.00% |
| Aptus Capital Advisors, LLC | 10,000 | $75.5K | 0.00% |
| Guardian Wealth Advisors, LLC | 10,000 | $75.5K | 0.00% |
Sold out (6)
Institutions that held Eupraxia Pharmaceuticals Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Logos Global Management LP | 900,000 | $5.31M |
| Alyeska Investment Group, L.P. | 250,000 | $1.48M |
| Guardian Partners Inc. | 24,130 | $147.4K |
| JPMorgan Chase & Co | 16,467 | $97.2K |
| Integrated Wealth Concepts LLC | 12,000 | $70.8K |
| Tower Research Capital LLC (TRC) | 9 | $53 |